Patent · US Active

Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells

US9409906B2 · kind B2 · utility

18Cited by

1References

49Claims

0Family size

Assignee

UNIVERSITE DE MONTREAL · CA

Inventors

Guy Sauvageau · Montréal, CA
Yves Gareau · Notre-Dame-de-l'Île-Perrot, CA
Rejean Ruel · Salaberry-de-Valleyfield, CA
Stéphane Gingras · Montréal, CA
Iman Fares · Montréal, CA

Key dates

Filing date	Jan 25, 2013
Grant date	Aug 9, 2016
Priority date	—
Expiry date	Jan 25, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations. The compounds are also useful in the medical treatment of diseases that involve hematopoietic stem cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.